Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine Formulations and Dextromethorphan for Chronic Cancer Pain
NCT00003687Phase 3Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Jun 1998
- Primary completion
- Sep 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of morphine, dextromethorphan in cancer pain, sponsored by Canadian Cancer Trials Group. Started Jun 1998; status: completed.
02
Drugs
morphinedextromethorphan
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT00003687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003687.